Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The U.S. Health and Human Services Department says it will require placebo testing of "all new vaccines," raising questions ...

"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

According to CBS News, the new guidance he is requesting is to include existing drugs, vitamins, and other modalities. In other news: RFK Jr. renews the disproved claim of aborted fetal cells in ...

Q1 2025 Earnings Call Transcript May 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.52, expectations ...

The proposed changes are linked to Robert F. Kennedy Jr., who this year was appointed to run the nation’s health department ...

The drug has been used in the U.S. for decades, but human trials of the drug in Africa found it cured individuals who had developed river blindness.

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

Clinical trials for the NIH's new universal flu vaccine are anticipated by 2026, with FDA approval by 2029. Other viruses like COVID and bird flu will follow.

The Department of Health and Human Services says it will require new vaccines to be tested against a placebo, which could ...